Ambulatory COVID-19 Patients Treated with Lactoferrin as a Supplementary Antiviral Agent: A Preliminary Study.

Rosa, Luigi; Tripepi, Giovanni; Naldi, Enrico; Aimati, Marina; Santangeli, Stefano; Venditto, Francesco; Caldarelli, Marcello; Valenti, Piera

Rosa, Luigi; Tripepi, Giovanni; Naldi, Enrico; Aimati, Marina; Santangeli, Stefano; Venditto, Francesco; Caldarelli, Marcello; Valenti, Piera.

Afiliación

Rosa L; Department of Public Health and Infectious Diseases, University of Rome "La Sapienza", 00185 Rome, Italy.
Tripepi G; National Research Council (CNR), Institute of Clinical Physiology (IFC), Clinical Epidemiology of Renal Diseases and Hypertension, Ospedali Riuniti, 89124 Reggio Calabria, Italy.
Naldi E; General Practitioner, 50136 Florence, Italy.
Aimati M; General Practitioner, 04011 Aprilia, Italy.
Santangeli S; General Practitioner, Barberino del Mugello, 50031 Florence, Italy.
Venditto F; General Practitioner, 50124 Florence, Italy.
Caldarelli M; General Practitioner, 00178 Rome, Italy.
Valenti P; Department of Public Health and Infectious Diseases, University of Rome "La Sapienza", 00185 Rome, Italy.

J Clin Med ; 10(18)2021 Sep 21.

Article en En | MEDLINE | ID: mdl-34575388

Palabras clave

COVID-19 patients; SARS-CoV-2; lactoferrin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_covid_19 Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google